U.S.: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment
FDA
Press Announcements
December 3, 2021 – FDA Expands Authorization of Two Monoclonal Antibodies for Treatment and Post-Exposure Prevention of COVID-19 to Younger Pediatric Patients, Including Newborns
November 30, 2021 – Coronavirus (COVID-19) Update: November 30, 2021
Vaccines and Related Biological Products Advisory Committee– FDA
https://www.fda.gov/advisory-committees/blood-vaccines-and-other-biologics/vaccines-and-related-biological-products-advisory-committee
No meetings on calendar
::::::
White House [U.S.]
Briefing Room – Selected Major COVID Announcements
Press Briefing by White House COVID-19 Response Team and Public Health Officials
December 03, 2021 Press Briefings
Remarks by President Biden on the COVID-19 Winter Plan
December 02, 2021 Speeches and Remarks
Background Press Call by Senior Administration Officials on New Actions to Protect Americans Against the Delta and Omicron Variants This Winter
December 02, 2021 Press Briefings
President Biden Announces New Actions to Protect Americans Against the Delta and Omicron Variants as We Battle COVID-19 this Winter
December 02, 2021 Statements and Releases
Statement from White House COVID-19 Response Coordinator Jeff Zients on First Case of the Omicron COVID-19 Variant in the United States
December 01, 2021• Statements and Releases
Press Briefing by White House COVID-19 Response Team and Public Health Officials
November 30, 2021 • Press Briefings
Readout of President Biden’s Meeting with COVID-19 Response Team on the Omicron Variant
November 28, 2021 Statements and Releases
U.S. Department of State
https://www.state.gov/coronavirus/releases/
Media Notes
Press Statement
Gayle Smith’s Service as the Coordinator for Global COVID-19 Response and Health Security
Antony J. Blinken November 30, 2021
vaccines and global health :: ethics and policy 